United Therapeutics Corporation’s UTHR shares declined 10.9% on the company’s first quarter earnings report which saw the company beating on earnings but missing on revenues. First quarter earnings came in at $4.84 per share, well …
One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put United Therapeutics Corporation UTHR stock into this equation and find out if it …
Mr. Christopher Causey is Independent Director of the Company. He has served as the Principal of the Causey Consortium, a professional services organization providing business strategy and marketing counsel to the healthcare …
Martine A Rothblatt , CEO of United Therapeutics Co. (NASDAQ:UTHR) reportedly Sold 1,259 shares of the company’s …
If you want a Stock Review on SHPG, AERI, HRTX, or UTHR then come over to http://dailystocktracker.com/register/ …
Shares are up after Jim Cramer spoke favorable of the stock on his “Mad Money” TV show. United Therapeutics Corporation (NASDAQ: UTHR) is down roughly 6% premarket to $58.90, relative to a 52-week range of $46.14-$70.74. …
United Therapeutics Corporation (NASDAQ:UTHR) stock surged on Friday as rumors of a takeover surged. The company is reportedly being considered as an acquisition by a major pharmaceutical giant, including Gilead Sciences Inc …
A covered call identified by MarketIntelligececenter.com's patented algorithm on United Therapeutics (UTHR) could yield about 4.42% (36.73% annualized, for comparison purposes only) in 44 days. Pair a long position in the stock with the …